Flotufolastat F-18 Gallium trials for Prostate Adenocarcinoma

All Flotufolastat F-18 Gallium trials · All Prostate Adenocarcinoma trials

Phase breakdown

Recruiting trials studying Flotufolastat F-18 Gallium for Prostate Adenocarcinoma

• An Investigational Scan (rhPSMA-7.3 PET/CT) for Detecting Biochemically Recurrent Prostate Cancer, ENLIGHTEN Trial
  NCT06813898 · Phase: Early Phase 1 · Ages: No age limits stated · Sex: Male · 1 location
• Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial
  NCT07025369 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance
  NCT05852041 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: Male · 1 location

Common questions

How many trials study Flotufolastat F-18 Gallium for Prostate Adenocarcinoma?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.